Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 4 studies | 21% ± 5% | |
epithelial cell | 3 studies | 30% ± 5% | |
ciliated cell | 3 studies | 17% ± 1% | |
GABAergic neuron | 3 studies | 18% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1377.64 | 1445 / 1445 | 100% | 14.04 | 183 / 183 |
ovary | 100% | 1251.39 | 180 / 180 | 100% | 13.72 | 430 / 430 |
uterus | 100% | 1508.22 | 170 / 170 | 100% | 21.11 | 459 / 459 |
lung | 100% | 1656.12 | 577 / 578 | 100% | 22.55 | 1155 / 1155 |
breast | 100% | 1173.94 | 459 / 459 | 100% | 19.98 | 1116 / 1118 |
intestine | 100% | 1282.73 | 966 / 966 | 100% | 12.65 | 526 / 527 |
bladder | 100% | 1575.62 | 21 / 21 | 100% | 17.07 | 503 / 504 |
prostate | 100% | 1496.09 | 245 / 245 | 100% | 14.93 | 501 / 502 |
brain | 100% | 1101.54 | 2629 / 2642 | 100% | 13.30 | 705 / 705 |
thymus | 100% | 1792.32 | 653 / 653 | 99% | 13.68 | 601 / 605 |
stomach | 100% | 1031.79 | 359 / 359 | 99% | 12.24 | 284 / 286 |
pancreas | 100% | 643.44 | 327 / 328 | 99% | 10.98 | 176 / 178 |
skin | 100% | 1806.30 | 1809 / 1809 | 98% | 15.25 | 464 / 472 |
adrenal gland | 100% | 1970.34 | 258 / 258 | 98% | 14.08 | 225 / 230 |
kidney | 100% | 1017.07 | 89 / 89 | 97% | 9.49 | 872 / 901 |
liver | 100% | 671.68 | 226 / 226 | 93% | 7.54 | 379 / 406 |
adipose | 100% | 1122.71 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1372.08 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.10 | 29 / 29 |
muscle | 100% | 1359.76 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1119.07 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.57 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.97 | 1 / 1 |
heart | 97% | 1283.37 | 838 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 6.89 | 70 / 80 |
peripheral blood | 52% | 483.20 | 479 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006974 | Biological process | DNA damage response |
GO_0006281 | Biological process | DNA repair |
GO_0051598 | Biological process | meiotic recombination checkpoint signaling |
GO_0071479 | Biological process | cellular response to ionizing radiation |
GO_0021762 | Biological process | substantia nigra development |
GO_0000077 | Biological process | DNA damage checkpoint signaling |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005694 | Cellular component | chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030896 | Cellular component | checkpoint clamp complex |
GO_0005634 | Cellular component | nucleus |
GO_0008311 | Molecular function | double-stranded DNA 3'-5' DNA exonuclease activity |
GO_0005515 | Molecular function | protein binding |
GO_0003684 | Molecular function | damaged DNA binding |
Gene name | RAD1 |
Protein name | RAD1 checkpoint DNA exonuclease Cell cycle checkpoint protein RAD1 (hRAD1) (Rad1-like DNA damage checkpoint protein) |
Synonyms | REC1 |
Description | FUNCTION: Component of the 9-1-1 cell-cycle checkpoint response complex that plays a major role in DNA repair . The 9-1-1 complex is recruited to DNA lesion upon damage by the RAD17-replication factor C (RFC) clamp loader complex . Acts then as a sliding clamp platform on DNA for several proteins involved in long-patch base excision repair (LP-BER) . The 9-1-1 complex stimulates DNA polymerase beta (POLB) activity by increasing its affinity for the 3'-OH end of the primer-template and stabilizes POLB to those sites where LP-BER proceeds; endonuclease FEN1 cleavage activity on substrates with double, nick, or gap flaps of distinct sequences and lengths; and DNA ligase I (LIG1) on long-patch base excision repair substrates . The 9-1-1 complex is necessary for the recruitment of RHNO1 to sites of double-stranded breaks (DSB) occurring during the S phase . . |
Accessions | ENST00000341754.8 [O60671-1] D6R9A1 ENST00000325577.8 [O60671-3] ENST00000382038.7 [O60671-1] O60671 ENST00000513914.5 |